Defective S-palmitoylation of NOD1/2 leads to severe immunologic and inflammatory diseases, including Crohn’s disease (CD), ulcerative colitis (UC), Blau syndrome, Behcet’s syndrome, early-onset sarcoidosis (EOS), and atopic diseases [92–94]. This evidence concerns the gene NOD1 and Blau syndrome.